Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT)

Q: What does CUSIP 097702104 represent in this 13F holders report?

CUSIP 097702104 is the security identifier for BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share in Q3 2025?

1 institutional investor reported BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share for Q3 2025. Use the holders table for investor-level position and value details.

CUSIP: 097702104

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class: Equity / Common Stock, par value $0.00001 per share
Total 13F shares: 139
Total 13F value: $90
Share change: +139
SEC-reported price per share: $0.65
Number of holders: 1
Value change: +$90
Number of buys: 1
Shares outstanding: 38,512,859

Security key

097702104

Report period

Q3 2025

Institutions

Top holders

BOLT full security history Ownership snapshot Newer quarter: Q4 2025 Bolt Biotherapeutics, Inc. SEC filings Bolt Biotherapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 097702104

Newer quarter: Q4 2025

Recent filing periods:

Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

TANG CAPITAL MANAGEMENT LLC

Disclosed value leader

Vivo Capital VIII, LLC

Comparable rows

1/15

Latest evidence

30 Jun 2025

13F 13D/G 3/4/5 Lead comparable stake: 3.5% 14 rows are not safely comparable across share classes. 13D/G row: TANG CAPITAL MANAGEMENT LLC Showing 1-6 of 15 holder rows.

Quick read

TANG CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 3.5%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TANG CAPITAL MANAGEMENT LLC's linked filing trail.

Comparable ownership Top 1

TANG CAPITAL MANAGEMENT LLC 3.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
TANG CAPITAL MANAGEMENT LLC	13F 13D/G Company 13F 13D/G	3.5% Reported 13D/G · 30 Sep 2025	$962,892 166,879 shares	—	30 Jun 2025
Vivo Capital VIII, LLC	3/4/5 10%+ Owner 3/4/5	— mixed-class rows	$5,435,517 5,763,311 shares mixed-class rows	—	21 Nov 2023
Novo Holdings A/S	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$3,518,791 3,703,991 shares	—	13 Jul 2022
Edgar Engleman	3/4/5 Director 3/4/5	— mixed-class rows	$1,969,355 2,098,005 shares mixed-class rows	—	29 Nov 2023
Vivo Capital, LLC	13F Company 13F	— denominator unverified	$985,958 176,064 shares	—	30 Jun 2025
Sofinnova Investments, Inc.	13F Company 13F	— denominator unverified	$794,650 137,721 shares	—	30 Jun 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Archived quarter

Historical 13F summary for Q3 2025

This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.

BOLT full security history Newer quarter: Q4 2025